(CARE) Careium - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0017131824

CARE EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CARE over the last 5 years for every Quarter.

CARE Revenue

This chart shows the Revenue of CARE over the last 5 years for every Quarter.

CARE: Safety Devices, Monitoring Systems, Alarms, Sensors, Assistive Technology

Careium AB is a leading provider of technology-enabled care services across Europe, operating in seven countries including Sweden, Norway, and the UK. The companys comprehensive range of products and services includes social alarms, sensors, cameras, and virtual monitoring services, all designed to enhance the safety and well-being of individuals, particularly the elderly and those with special needs.

Careiums product portfolio is diverse and innovative, featuring solutions such as Visit, a virtual monitoring service that replaces physical home visits, and Eliza S, a welfare hub that offers advanced security and reliability for service users and providers. The companys focus on developing and integrating technology into care services positions it at the forefront of the care industrys digital transformation.

From a technical analysis perspective, the stock has shown a positive trend, with its last price of 32.50 SEK being above its 20-day and 50-day moving averages, indicating a potential uptrend. The Average True Range (ATR) of 0.99 suggests a moderate level of volatility, with a daily price movement of around 3.05%. Given the current technical indicators, a potential forecast could be that the stock continues to trend upwards, potentially reaching its 52-week high of 36.60 SEK.

Fundamentally, Careiums market capitalization stands at 766.28M SEK, with a price-to-earnings ratio of 13.13, indicating that the stock may be undervalued relative to its earnings. The return on equity (RoE) of 7.92% suggests that the company is generating profits from its shareholders equity. Combining these fundamental insights with the technical analysis, a forecast could be that Careiums stock price will continue to rise as the companys financial performance and innovative product offerings drive investor confidence.

Taking into account both the technical and fundamental data, a potential investment strategy could involve monitoring the stocks price action around its moving averages and watching for any significant changes in its ATR. If the stock continues to trend upwards and breaks through its 52-week high, it could be a signal for a potential long position. Conversely, a drop below its 50-day moving average could indicate a potential sell signal.

Additional Sources for CARE Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CARE Stock Overview

Market Cap in USD 81m
Sector Industrials
Industry Security & Protection Services
GiC Sub-Industry Security & Alarm Services
IPO / Inception

CARE Stock Ratings

Growth Rating 3.83
Fundamental 51.6
Dividend Rating 0.0
Rel. Strength -17.6
Analysts -
Fair Price Momentum 28.00 SEK
Fair Price DCF 20.41 SEK

CARE Dividends

Currently no dividends paid

CARE Growth Ratios

Growth Correlation 3m 47.3%
Growth Correlation 12m -48.9%
Growth Correlation 5y 69.7%
CAGR 5y -0.98%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m -0.11
Alpha -5.55
Beta 0.436
Volatility 44.42%
Current Volume 7.1k
Average Volume 20d 17.8k
What is the price of CARE shares?
As of July 01, 2025, the stock is trading at SEK 31.00 with a total of 7,095 shares traded.
Over the past week, the price has changed by -1.90%, over one month by +8.39%, over three months by +3.33% and over the past year by +2.31%.
Is Careium a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, Careium (ST:CARE) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.57 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CARE is around 28.00 SEK . This means that CARE is currently overvalued and has a potential downside of -9.68%.
Is CARE a buy, sell or hold?
Careium has no consensus analysts rating.
What are the forecasts for CARE share price target?
According to our own proprietary Forecast Model, CARE Careium will be worth about 30.8 in July 2026. The stock is currently trading at 31.00. This means that the stock has a potential downside of -0.61%.
Issuer Target Up/Down from current
Wallstreet Target Price 30.5 -1.6%
Analysts Target Price - -
ValueRay Target Price 30.8 -0.6%